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Nonketotic hyperglycemia induced occipital lobe
seizures: a case report
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ABSTRACT
Typically, nonketotic hyperglycemia induces partial motor seizures. We present a rare
case of nonketotic hyperglycemia induced occipital lobe seizures and discuss the
impact of hemoglobin A1c on seizure activity, typical imaging results, and use of antiepileptic drugs in management.
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INTRODUCTION
Occipital lobe epilepsy accounts for five to ten
percent of all epilepsies.1 While idiopathic occipital
lobe epilepsy has an age of onset in childhood
or adolescence,2 symptomatic occipital lobe
seizures may start at any age depending on the
underlying disorder provoking seizure onset.1 Clinical
manifestations include elementary and complex
visual hallucinations, ictal amaurosis, visual illusions,
sensory hallucinations of ocular movements,
oculomotor symptoms, nystagmus, and repetitive
eye closure or eyelid fluttering.1 Occipital seizures
may be provoked by multiple etiologies including
posterior reversible encephalopathy syndrome
(PRES), metabolic encephalopathies, malformations
of cortical development, trauma, vascular
disturbances, tumors, or infection/ inflammation.2 A
rare cause of provoked occipital seizures is nonketotic
hyperglycemia, a syndrome consisting of severe
hyperglycemia, hyperosmolality, and intracellular
dehydration without ketoacidosis.3 Nonketotic
hyperglycemia often causes partial motor seizures
with or without secondary generalization; however,
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there have been a few reported cases of nonketotic
hyperglycemia provoking occipital lobe seizures.4
CASE REPORT
A previously healthy 59-year-old man with no past
medical history and no primary care physician
presented to the emergency department (ED)
with acute onset headache for the past four days
with associated left lower field visual changes and
metamorphopsia. Vitals were within normal limits
except for increased blood pressures as high as
218/105. CT scan with and without contrast at this
time showed no acute intracranial process with a
probable old lacunar infarct of the left thalamus. His
labs were within normal limits except for an elevated
glucose of 242 and white blood cell count of 14.8. His
hemoglobin A1c (HbA1C) was not evaluated, and he
left against medical advice.
The patient returned to the ED two days later with
hypertension and left hemianopsia. His blood
pressure was 195/98. Repeat CT angiography showed
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6.3 mm left sided cavernous carotid aneurysm and
increased mean transit time (MTT). The next day,
the patient complained of blurry vision and left eye
deviation with visual hallucinations consisting of two
green and red pinwheels floating from the left to the
right of his visual field. A stat electroencephalography
(EEG) was ordered which showed six seizures
originating from the right occipital lobe. Patient also
hallucinated various types of dogs, children, and
men during seizures. Patient had 13 partial right
occipital lobe seizures in 74 minutes. He was given
4 mg Lorazepam, 1000 mg Valproate, and 1000
mg Levetiracetam twice daily with no change in
seizure frequency. He continued to have 11 seizures
over the next 90 minutes, each around 40 seconds
in length. He was given another 4 mg Lorazepam.
Levetiracetam was increased to 1300 mg every eight
hours and Valproate was increased to 500 mg every
six hours when he continued to seize the following
day. He was intubated and sedated with Midazolam
at this time. Seizure activity slowed to two seizures
per hour then gradually to one per hour. The patient
was seizure free by the third day of hospitalization.
His glucose level decreased to the high 100’s for
the rest of his hospital stay. Patient was discharged
on day 12. On follow up, he continued 1000 mg
Valproate and 2000 mg Levetiracetam twice daily. He
has been seizure free for fifteen months. His type 2
diabetes (T2DM) was treated and he has maintained a
HbA1c under 7.8% since discharge.
DISCUSSION
Onset of epileptic seizures over age 50 is
highly suggestive of a lesion or metabolically
provoked process.5 Seizures related to nonketotic
hyperglycemia are typically partial seizures that are
refractory to antiepileptic drugs (AED) and resolve
with treatment of hyperglycemia.6 Although our
patient had only mildly elevated glucose levels
on admission, his HbA1c was highly elevated at
14.8%. This is in agreement with case reports which
conclude that long standing hyperglycemia, rather
than an acute rise in glucose levels, is the likely cause
of seizure onset.4,7 In fact, half of patients presenting
with epileptic seizures in the setting of nonketotic
hyperglycemia have undiagnosed diabetes,5 as seen
in our patient.
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On admission, our patient was found to have
prolonged MTT in posterior cerebral arteries
bilaterally. The ictal state is most associated with
increased perfusion to focal area of epileptiform
activity, while the postictal state is associated with
focal hypoperfusion. In a study by Gelfand et al.,
thirty seven percent of patients had perfusion CT
abnormalities in post-ictal state, with prolonged MTT
and decreased cerebral blood volume (CBV) and
cerebral blood flow (CBF) being the most common.8
The cerebral blood flow changes during the course
of seizure, from marked increase in ictal to a deep
decrease in postictal state.9 Due to these findings,
we conclude that our patient with prolonged MTT
was in the postictal state during his CT on admission.
Nonketotic hyperglycemia related occipital lobe
seizures have been associated with subcortical
hypointensity in occipital lobes on T2 weighted
MRI. This is different from the hyperintensity of
the occipital region often found in PRES.7 When
comparing several case reports of nonketotic
hyperglycemia induced occipital seizures, ten out
of eleven patients had this characteristic transient
hypointensity of the occipital region.4 As far as
we know, this is only the second case reporting
nonketotic hyperglycemia induced occipital lobe
seizures without MRI changes.
The pathology behind nonketotic hyperglycemia
induced occipital lobe seizures is still unclear. It
has been hypothesized that the seizure threshold
decreases due to metabolic disturbance induced
by chronic hyperglycemia.6 Another hypothesis
predicts that previously existing cortical lesions
lead to seizure under the metabolic disturbance,6
and pre-existing lesions may predispose a certain
population to focal seizures with hyperglycemia,10
such as with our patient who showed chronic small
vessel ischemic change on MRI. Also, the neuronal
potassium ATP channels may be related to the
neuroexcitability in the hyperglycemic state.10
In conclusion, our patient continued to seize for
three days despite increasing dosage of AED.
While in the hospital, he was also treated for his
hyperglycemia, which we believe ultimately resulted
in the gradual resolution of his seizures. The typical
time elapsed from glycemic control to seizure
cessation ranges from 24 hours to four days.5 He has

mds.marshall.edu/mjm
© 2022 Marshall Journal of Medicine

Marshall Journal of Medicine
Volume 4 Issue 3

continued the AED regimen as well as antidiabetic
therapy for 15 months post admission, keeping
HbA1c level under 7.8% with no seizure recurrence.
Per Scherer, AED therapy should not be initiated
or continued once seizures are under control.5
However, one case reported recurrence of occipital
lobe seizures nine months after primary admission
with loss of diabetic control without AED therapy.3
We propose that prophylactic therapy may be
necessary until HbA1c is in the acceptable range.
Our patient has attained glucose control, and a trial
period without AED should be initiated.
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